knowledge -WSS

knowledge

author：leisure time 2025-09-29 23:04:47 - browse：6811

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How to ethically and practically extend health care to all

WSS

The cancer stories no one wants to hear

A strong 6.5

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Flint parents haunted by uncertainty, fears of lead poisoning

Biden administration sends mixed signals on US soldier who crossed into North Korea

Heart disease in astronauts blamed on cosmic radiation

entertainment

knowledge

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

'Null' research findings aren't empty of meaning. Let's publish them

Malaria cases in Florida and Texas: Here’s what you need to know

Biden administration sends mixed signals on US soldier who crossed into North Korea

Supreme Court strikes down use of affirmative action

Study: Hearing aids may slow cognitive decline in those at risk

Anesthesiologist group: stop taking Ozempic before surgery

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

After affirmative action ruling, medical educators look to 'holistic review'

H.R. 3 is the wrong path to lower drug costs

focus

Why you get paid to donate plasma but not blood

Late stage cancers on the rise after pandemic delayed screenings

CDC recommends RSV monoclonal antibody for infants

Manchin plays down potential 3rd

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

focus

hotspot

focus

entertainment